Quality of service provision for anticoagulation in atrial fibrillation. Cardioversion should be attempted

Comment

R C Davis. BMJ. 1996.

. 1996 Jan 6;312(7022):52.

doi: 10.1136/bmj.312.7022.52a.

No abstract available

Comment on

Service provision and use of anticoagulants in atrial fibrillation.
Sudlow CM, Rodgers H, Kenny RA, Thomson RG. Sudlow CM, et al. BMJ. 1995 Aug 26;311(7004):558-60. doi: 10.1136/bmj.311.7004.558. BMJ. 1995. PMID: 7663216 Free PMC article.

Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi.
Manning WJ, Silverman DI, Gordon SP, Krumholz HM, Douglas PS. Manning WJ, et al. N Engl J Med. 1993 Mar 18;328(11):750-5. doi: 10.1056/NEJM199303183281102. N Engl J Med. 1993. PMID: 8437595 Clinical Trial.
Electrical and pharmacologic cardioversion for atrial fibrillation.
Kim SS, Knight BP. Kim SS, et al. Med Clin North Am. 2008 Jan;92(1):101-20, xi. doi: 10.1016/j.mcna.2007.08.003. Med Clin North Am. 2008. PMID: 18061000 Review.
Anticoagulation for cardioversion of atrial fibrillation.
El Gendi H, Ismail T, Charalampos K, Mayet J. El Gendi H, et al. Minerva Cardioangiol. 2002 Feb;50(1):43-52. Minerva Cardioangiol. 2002. PMID: 11830718 Review.
Prevention of embolic events after cardioversion of atrial fibrillation. Current and evolving strategies.
Kinch JW, Davidoff R. Kinch JW, et al. Arch Intern Med. 1995 Jul 10;155(13):1353-60. Arch Intern Med. 1995. PMID: 7794083 Review.
Cardioversion of atrial arrhythmias: audit of anticoagulation management.
Mayet J, Wasan B, Sutton GC. Mayet J, et al. J R Coll Physicians Lond. 1997 May-Jun;31(3):313-6. J R Coll Physicians Lond. 1997. PMID: 9192336 Free PMC article.